CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia
Authors
A. Tischer Andrews, N. Kafatos, G. Nardone, A. Berbers, G. Davidkin, I. Aboudy, Y. Backhouse, J. Barbara, C. Bartha, K. Bruckova, B. Ducks, A. Griskevicius, A. Hesketh, L. Johansen, K. Jones, L. Kuersteiner, O. Lupulescu, E. Mihneva, Z. Mrazova, M. De Ory, F. Prosenc, K. Schneider, F. Tsakris, A. Smelhausova, M. Vranckx, R. Zarvou, M. Miller, E.
Publication date
1 January 2007
Publisher
Abstract
The aim of the European Sero-Epidemiology Network is to establish comparability of the serological surveillance of vaccine-preventable diseases in Europe. The designated reference laboratory (RL) for measles, mumps, rubella (MMR) prepared and tested a panel of 151 sera by the reference enzyme immunoassay (rEIA). Laboratories in 21 countries tested the panel for antibodies against MMR using their usual assay (a total of 16 different EIAs) and the results were plotted against the reference results in order to obtain equations for the standardization of national serum surveys. The RL also tested the panel by the plaque neutralization test (PNT). Large differences in qualitative results were found compared to the RL. Well-fitting standardization equations with R2≥0.8 were obtained for almost all laboratories through regression of the quantitative results against those of the RL. When compared to PNT, the rEIA had a sensitivity of 95.3%, 92.8% and 100% and a specificity of 100%, 87.1% and 92.8% for measles, mumps and rubella, respectively. The need for standardization was highlighted by substantial inter-country differences. Standardization was successful and the selected standardization equations allowed the conversion of local serological results into common units and enabled direct comparison of seroprevalence data of the participating countries. © 2007 Cambridge University Press
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3113201
Last time updated on 10/02/2023